One Size May Not Fit All Is Extended Pharmacologic Venous Thromboembolism Prophylaxis Uniformly Safe After Radical Cystectomy?UrologyVol. 84Issue 5PreviewTo quantitate the risk of clinically significant renal function deterioration after radical cystectomy (RC), which could result in supratherapeutic levels of low-molecular-weight heparin (LMWH) and increased risk of bleeding events with the use of extended pharmacologic venous thromboembolism prophylaxis (EPVTEP) after hospital discharge. Full-Text PDF ReplyUrologyVol. 84Issue 5PreviewDeep-vein thrombosis and pulmonary thromboembolism are the major and potentially lethal complications of abdominal or pelvic cancer surgery. A noteworthy proportion of symptomatic venous thromboembolic events occur after hospital discharge. Appropriately, national guidelines recommend the use of extended pharmacologic venous thromboembolism prophylaxis (EPVTEP) for 4-week duration after pelvic surgery, including radical cystectomy. Nevertheless, such recommendations may not be appropriate for all patients. Full-Text PDF